Notably, the "Androgen Up-regulated Genes" (86 genes [29,30]) and "Breast Cancer Estrogen Signaling" (101 genes [30]) GO categories both are identified at 0% false discovery rate, with AR presenting as the top ranked gene in the "Breast Cancer Estrogen Signaling" category; three genes overlap between the two profiles used to define the GO categories. This evidence concerns the gene AR and breast carcinoma.